| |
| |
|
| Insider
Information: |
Markham Richard J |
| Relationship: |
Director, 10% Owner |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
35,034,767 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$31,409,543 |
|
|
| Total
Shares |
35,034,767 |
|
|
| Total
Value |
$31,409,543 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acura Pharmaceuticals Inc |
ACUR |
Director |
2009-03-24 |
0 |
2010-03-05 |
0 |
Premium* |
|
|
Nephrogenex, Inc. |
NRX |
Director, 10% Owner |
2014-02-14 |
0 |
2014-02-14 |
4,241,097 |
Premium* |
|
|
Vaxart Inc |
VXRT |
Director, 10% Owner |
2018-02-13 |
0 |
2018-02-13 |
30,793,670 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VXRT |
Vaxart Inc |
Director |
– • • |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,793,670 |
30,793,670 |
0 |
- |
|
| NRX |
Nephrogenex, Inc. |
Director |
– • • |
2014-02-14 |
4 |
B |
$12.00 |
$9,480,000 |
I/I |
790,000 |
4,241,097 |
2.25 |
- |
|
| NRX |
Nephrogenex, Inc. |
Director |
– • • |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
412,592 |
3,451,097 |
0 |
- |
|
| NRX |
Nephrogenex, Inc. |
Director |
– • • |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
3,038,505 |
3,038,505 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2010-03-05 |
4 |
S |
$4.77 |
$52,103 |
I/I |
(10,923) |
0 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-05-26 |
4 |
S |
$7.38 |
$73,800 |
I/I |
(10,000) |
10,923 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-05-22 |
4 |
S |
$7.50 |
$43,500 |
I/I |
(5,800) |
20,923 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-05-20 |
4 |
S |
$7.34 |
$44,040 |
I/I |
(6,000) |
26,723 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-05-15 |
4 |
S |
$7.04 |
$9,420 |
I/I |
(1,338) |
32,723 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-05-13 |
4 |
S |
$7.05 |
$49,547 |
I/I |
(7,028) |
34,061 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-05-08 |
4 |
S |
$6.93 |
$73,458 |
I/I |
(10,600) |
41,089 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-05-07 |
4 |
S |
$6.91 |
$89,139 |
I/I |
(12,900) |
51,689 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-05-06 |
4 |
S |
$6.79 |
$82,159 |
I/I |
(12,100) |
64,589 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Director |
– • – |
2009-03-24 |
4 |
S |
$7.11 |
$248,850 |
I/I |
(35,000) |
76,689 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
